|
|
Previous Article | Table of Contents | Next Article 
Overexpression of PU.1 induces growth and differentiation inhibition and
apoptotic cell death in murine erythroleukemia cells
T Yamada, N Kondoh, M Matsumoto, M Yoshida, A Maekawa and T Oikawa
Department of Cell Genetics, Sasaki Institute, Tokyo, Japan.
PU.1 is a member of the ets family of transcription factors and is
expressed in Friend virus-induced murine erythroleukemia (MEL) cells as a
consequence of proviral integration into the PU.1/Spi-1 locus. After
induction of MEL cell differentiation by treatment with dimethylsulfoxide
(DMSO), expression of the PU.1/Spi-1 gene decreased before induction of
beta-globin gene expression. Overexpression of PU.1 by using a
zinc-inducible expression plasmid in MEL cells resulted in unexpected
growth inhibition of the transfectants. When PU.1- overexpressing
transfectants were treated with DMSO, growth inhibition became much
pronounced and apoptosis was induced. Expression of the beta-globin gene
was not induced under this condition. Neither growth inhibition nor
apoptosis was induced in MEL cells after expression of mutant PU.1 proteins
with a deletion of the activation domain or the DNA-binding Ets domain
irrespective of the presence of DMSO. Interestingly, beta-globin gene
expression was not induced in the transfectants expressing the former
mutant, whereas it was induced in those expressing the latter one in the
presence of DMSO. These results indicate that overexpression of PU.1 in MEL
cells results in growth and differentiation inhibition and, in conjunction
with DMSO treatment, apoptotic cell death. These results also suggest that
the activation domain and the Ets domain of PU.1 contribute differently to
induction of these effects.
Volume 89,
Issue 4,
pp. 1383-1393,
02/15/1997
Copyright © 1997 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Yang, L. Wang, T. A. Kalfa, J. A. Cancelas, X. Shang, S. Pushkaran, J. Mo, D. A. Williams, and Y. Zheng
Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis
Blood,
December 1, 2007;
110(12):
3853 - 3861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rimmele, O. Kosmider, P. Mayeux, F. Moreau-Gachelin, and C. Guillouf
Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation
Blood,
April 1, 2007;
109(7):
3007 - 3014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Liew, K. D. Rand, R. J. Y. Simpson, W. W. Yung, R. E. Mansfield, M. Crossley, M. Proetorius-Ibba, C. Nerlov, F. M. Poulsen, and J. P. Mackay
Molecular Analysis of the Interaction between the Hematopoietic Master Transcription Factors GATA-1 and PU.1
J. Biol. Chem.,
September 22, 2006;
281(38):
28296 - 28306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kawagoe, M. Potter, J. Ellis, and G. C. Grosveld
TEL2, an ETS Factor Expressed in Human Leukemia, Regulates Monocytic Differentiation of U937 Cells and Blocks the Inhibitory Effect of TEL1 on Ras-Induced Cellular Transformation
Cancer Res.,
September 1, 2004;
64(17):
6091 - 6100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Back, A. Dierich, C. Bronn, P. Kastner, and S. Chan
PU.1 determines the self-renewal capacity of erythroid progenitor cells
Blood,
May 15, 2004;
103(10):
3615 - 3623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rekhtman, K. S. Choe, I. Matushansky, S. Murray, T. Stopka, and A. I. Skoultchi
PU.1 and pRB Interact and Cooperate To Repress GATA-1 and Block Erythroid Differentiation
Mol. Cell. Biol.,
November 1, 2003;
23(21):
7460 - 7474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Choe, F. Radparvar, I. Matushansky, N. Rekhtman, X. Han, and A. I. Skoultchi
Reversal of Tumorigenicity and the Block to Differentiation in Erythroleukemia Cells by GATA-1
Cancer Res.,
October 1, 2003;
63(19):
6363 - 6369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Starck, N. Cohet, C. Gonnet, S. Sarrazin, Z. Doubeikovskaia, A. Doubeikovski, A. Verger, M. Duterque-Coquillaud, and F. Morle
Functional Cross-Antagonism between Transcription Factors FLI-1 and EKLF
Mol. Cell. Biol.,
February 15, 2003;
23(4):
1390 - 1402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kitagawa, S. Yamaguchi, M. Hasegawa, K. Tanaka, T. Sado, K. Hirokawa, and S. Aizawa
Friend Leukemia Virus Infection Enhances DNA Damage-Induced Apoptosis of Hematopoietic Cells, Causing Lethal Anemia in C3H Hosts
J. Virol.,
June 27, 2002;
76(15):
7790 - 7798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Hong, A. Y. Kim, S. Ky, C. Rakowski, S.-B. Seo, D. Chakravarti, M. Atchison, and G. A. Blobel
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Mol. Cell. Biol.,
June 1, 2002;
22(11):
3729 - 3743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamada, M. Abe, T. Higashi, H. Yamamoto, F. Kihara-Negishi, T. Sakurai, T. Shirai, and T. Oikawa
Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells
Blood,
April 15, 2001;
97(8):
2300 - 2307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhang, X. Zhang, A. Iwama, C. Yu, K. A. Smith, B. U. Mueller, S. Narravula, B. E. Torbett, S. H. Orkin, and D. G. Tenen
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Blood,
October 15, 2000;
96(8):
2641 - 2648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Matsumura, A. Kawasaki, H. Tanaka, J. Sonoyama, S. Ezoe, N. Minegishi, K. Nakajima, M. Yamamoto, and Y. Kanakura
Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines
Blood,
October 1, 2000;
96(7):
2440 - 2450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rekhtman, F. Radparvar, T. Evans, and A. I. Skoultchi
Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells
Genes & Dev.,
June 1, 1999;
13(11):
1398 - 1411.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. L. Hilbert, R. E. Luna, J. Zhang, Y. Wang, R. A. Hopkins, Z.-X. Yu, and V. J. Ferrans
ALLOGRAFT HEART VALVES: THE ROLE OF APOPTOSIS-MEDIATED CELL LOSS
J. Thorac. Cardiovasc. Surg.,
March 1, 1999;
117(3):
454 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Starck, A. Doubeikovski, S. Sarrazin, C. Gonnet, G. Rao, A. Skoultchi, J. Godet, I. Dusanter-Fourt, and F. Morle
Spi-1/PU.1 Is a Positive Regulator of the Fli-1 Gene Involved in Inhibition of Erythroid Differentiation in Friend Erythroleukemic Cell Lines
Mol. Cell. Biol.,
January 1, 1999;
19(1):
121 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Fisher, M. C. Olson, J. M. R. Pongubala, J. M. Perkel, M. L. Atchison, E. W. Scott, and M. C. Simon
Normal Myeloid Development Requires Both the Glutamine-Rich Transactivation Domain and the PEST Region of Transcription Factor PU.1 but Not the Potent Acidic Transactivation Domain
Mol. Cell. Biol.,
July 1, 1998;
18(7):
4347 - 4357.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. C. Fisher and E. W. Scott
Role of PU.1 in Hematopoiesis
Stem Cells,
January 1, 1998;
16(1):
25 - 37.
[Abstract]
[Full Text]
|
 |
|
|
|